Latest Breaking News On - திட கட்டம் - Page 1 : comparemela.com

Cervical Dysplasia Market Size Worth $936 4 Million By 2028 | CAGR: 7 5%: Polaris Market Research

Share this article Share this article USD 936.4 million by 2028 according to a new study conducted by Polaris Market Research. The market is anticipated to register a CAGR of 7.5% From 2021 – 2028. A rise in the vulnerability of women diagnosed with cervical dysplasia and growing awareness among people for investing more in getting regular check-ups for their health are the key factors driving the market growth. In addition to this, medical practitioners are also working to improve their functional systems to effectively manage the disease diagnosis and monitoring, which in turn boosting the overall development of the market. A rise in the number of awareness programs and initiatives for spreading the importance of the early diagnosis of the disease is further complements the growth of the market.

New yorkUnited statesSouth africaSaudi arabiaSouth koreaAsia pacificPolaris market researchCoopersurgical incTechnology agglutinationHealthcare industryby polaris market researchOncohealth corporation incProduct service typeHologic incResearch summary on cervical dysplasia marketWorld health organizationSurgical centers

New Concerns about PFAS in Food: The Convergence of Environmental Contamination and Food Safety

Feb 04 2021 Read 19037 Times Author: David C. Kennedy on behalf of Phenomenex Inc Free to read Unlock Per and Polyfluorinated Alkyl Substances (PFAS) are well known environmental contaminants that have a newly recognised potential to taint certain food products through agricultural consumption via environmental transport from contaminated industrial sites [1]. The analysis of PFAS in food products requires more extensive analytical preparation techniques, compared to PFAS testing of simple matrices such as drinking water, in order to reduce the impact of sample matrix interferences on the subsequent instrumental analysis. An example is provided of a PFAS method applicable to milk, butter, cheese and fish.

United statesCity of industryPhenomenex luna omegaAgustin pierri weckAgustin pierriDrug administrationUs environmental protection agencyPhenomenex incWeck laboratories incScott krepich phenomenex incCommunicable disease centerUs department of defenseAgency for toxic substancesPolyfluorinated alkyl substancesProtection agencyUnregulated contaminant monitoring rule

Global Rapid Test Kit Markets 2021-2026 by Type, Product, Technology, Duration, Application, End Users, & Region

Share this article Share this article ResearchAndMarkets.com s offering. The Global Rapid Test Kit Market was valued at USD 23.44 Billion in 2020 and is expected to grow at a formidable rate of 8.14% during the forecast period. The Global Rapid Test Kit Market is driven by the growing prevalence of various infectious diseases. Additionally, benefits associated with rapid test kits such as low cost, accuracy, early disease diagnosis, quick results, stability at high temperature, among others are further expected to propel the market growth through 2026. Moreover, sudden outbreak and spread of pandemic COVID-19 has drastically increased the demand for rapid test kits, thereby fueling the market growth during the forecast period. Many major biotechnology and pharmaceutical companies have developed their own rapid test kits, and many are still investing, researching and working on the development of better and advanced rapid test kits. This in turn is expected to create lucrative

United statesUnited kingdomSouth africaSaudi arabiaSouth koreaLaura woodDanaher corporation cepheid incPerkinelmer incCellex incAbbott laboratories ltdMesa biotech incTechnology lateral flow assaysOrasure technologies incCustom researchOffice hours callResearch methodology

Lewy Body Dementia Treatment Market Size Worth $5 31 Billion By 2027

is projected to reach USD 5.31 billion by 2027 according to a new study conducted by Polaris Market Research the market is anticipated to register a CAGR of 5.1% from 2020 to 2027. An increasingly aging population has gradually resulted in a rise of cases of lewy body dementia, which is one of the primary factors driving the growth of the global market. A higher number of dementia cases in developed countries are creating strong demand for effective drugs and leading manufacturers bringing new products tailored to cure the disease are expected to fuel significant demand for dementia treatment in the global market. An increased government effort to spread awareness regarding the treatment for lewy body dementia and the rising prevalence of brain-related disorders is foreseen to strengthen the market growth.

New yorkUnited statesUnited kingdomSouth africaSaudi arabiaSouth koreaHarryt mangurian jrAsia pacificJazz pharmaceuticals incPolaris market researchMallinckrodt pharmaceuticalsTechnology agglutinationJanssen pharmaceuticals incBrain healthTakeda pharmaceutical company ltdFlorida atlantic university schmidt college of medicine

Peptide Therapeutics Market Research 2020-2025: Market Analysis, Drivers, Restraints, Opportunities, and Threats

Peptide Therapeutics Market Research 2020-2025: Market Analysis, Drivers, Restraints, Opportunities, and Threats
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSouth africaJohn bayAsia pacificEli lillyNovo nordiskCordenpharma internationalProduct service landscapeCompany overviewTeva pharmaceuticalResearch methodologyCompany nameMerck coAstrazeneca plcMarket research engine